Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Clark

Showing results (1501-1510 of 1,669) with videos related to

Pageof 167
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, Geoffrey I Shapiro, Roger B Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling SurveysRazelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 17, 2026
Using fish models to understand the role of aryl hydrocarbon receptor (AHR)-interacting protein (AIP) in controlling sensitivity and resistance to dioxin-like compounds in vivoSibel I Karchner, Neelakanteswar Aluru, Diana G Franks, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinibJochen K Lennerz, Eunice L Kwak, Allison Ackerman, et al.
The Oncologist|August 23, 2020
Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal CanalGrace Lee, Daniel W Kim, Vinayak Muralidhar, et al.
Viruses|April 30, 2021
Comparison of Serological Assays for the Detection of SARS-CoV-2 AntibodiesJoe James, Shelley Rhodes, Craig S Ross, et al.
Cardiovascular Diabetology|December 8, 2025
Comprehensive CMR evaluation including 4D flow-derived E/A vorticity ratio in overweight adults with and without type 2 diabetes mellitusSungho Park, Erin K Englund, Takashi Fujiwara, et al.
Respiratory Research|May 22, 2021
Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19T J M Wallis, E Heiden, J Horno, et al.
Pageof 167

Showing results (1501-1510 of 1,669) with videos related to

Sort By:
Pageof 167
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, Geoffrey I Shapiro, Roger B Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling SurveysRazelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 17, 2026
Using fish models to understand the role of aryl hydrocarbon receptor (AHR)-interacting protein (AIP) in controlling sensitivity and resistance to dioxin-like compounds in vivoSibel I Karchner, Neelakanteswar Aluru, Diana G Franks, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinibJochen K Lennerz, Eunice L Kwak, Allison Ackerman, et al.
The Oncologist|August 23, 2020
Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal CanalGrace Lee, Daniel W Kim, Vinayak Muralidhar, et al.
Viruses|April 30, 2021
Comparison of Serological Assays for the Detection of SARS-CoV-2 AntibodiesJoe James, Shelley Rhodes, Craig S Ross, et al.
Cardiovascular Diabetology|December 8, 2025
Comprehensive CMR evaluation including 4D flow-derived E/A vorticity ratio in overweight adults with and without type 2 diabetes mellitusSungho Park, Erin K Englund, Takashi Fujiwara, et al.
Respiratory Research|May 22, 2021
Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19T J M Wallis, E Heiden, J Horno, et al.
Pageof 167